Hyperfine (HYPR) announced that it has received FDA clearance for a new multi-direction diffusion-weighted imaging software sequence. This advancement delivers substantially improved image quality and diagnostic confidence for stroke detection, marking a significant expansion of the Swoop system’s clinical capabilities in acute neurological care.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HYPR: